Hydralazine Valproate for Ovarian Cancer

NCT00533299 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

211

Enrollment

OTHER_GOV

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Hydralazine and magnesium valproate
DRUG: Placebo

Sponsor

National Institute of Cancerología